Jesper Lau

6.4k total citations · 3 hit papers
74 papers, 4.2k citations indexed

About

Jesper Lau is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jesper Lau has authored 74 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 29 papers in Organic Chemistry and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jesper Lau's work include Organic and Molecular Conductors Research (15 papers), Diabetes Treatment and Management (14 papers) and Carbohydrate Chemistry and Synthesis (9 papers). Jesper Lau is often cited by papers focused on Organic and Molecular Conductors Research (15 papers), Diabetes Treatment and Management (14 papers) and Carbohydrate Chemistry and Synthesis (9 papers). Jesper Lau collaborates with scholars based in Denmark, United States and United Kingdom. Jesper Lau's co-authors include Lotte Bjerre Knudsen, Kjeld Madsen, Jan Becher, Henning Thøgersen, John Paul Kilburn, Rainer Rudolph, S. Runge, Sanne Møller Knudsen, Raymond C. F. Jones and Thomas Kruse and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Jesper Lau

72 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide

2015 736 citations Jesper Lau, Kjeld Madsen et al. Journal of Medicinal Chemistry profile →
The Discovery and Development of Liraglutide and Semaglutide

2019 601 citations Lotte Bjerre Knudsen, Jesper Lau Frontiers in Endocrinology profile →
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

2016 288 citations Chris de Graaf, Daniel J Donnelly et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesper Lau Denmark	31	2.2k	1.6k	843	802	642	74	4.2k
Matthew C. T. Fyfe United Kingdom	28	904 0.4×	458 0.3×	2.0k 2.3×	274 0.3×	420 0.7×	53	3.5k
Hongbin Sun China	41	3.6k 1.7×	457 0.3×	1.8k 2.2×	217 0.3×	217 0.3×	210	7.4k
Matthias U. Kassack Germany	48	2.9k 1.3×	278 0.2×	1.1k 1.3×	413 0.5×	281 0.4×	153	5.5k
Vasanthy Narayanaswami United States	33	1.8k 0.8×	479 0.3×	290 0.3×	271 0.3×	586 0.9×	85	3.4k
Bernard Pirotte Belgium	38	1.8k 0.8×	157 0.1×	1.7k 2.0×	610 0.8×	264 0.4×	229	4.2k
Lusiane Maria Bendhack Brazil	31	689 0.3×	274 0.2×	238 0.3×	133 0.2×	251 0.4×	157	3.2k
Ingrid Pettersson Denmark	22	1.2k 0.6×	508 0.3×	420 0.5×	199 0.2×	242 0.4×	47	2.1k
Bruce E. Maryanoff United States	52	3.5k 1.6×	242 0.2×	6.8k 8.1×	840 1.0×	347 0.5×	265	11.7k
Hervé Galons France	32	2.1k 1.0×	400 0.3×	726 0.9×	152 0.2×	101 0.2×	154	4.1k
Linda J. Roman United States	36	1.6k 0.8×	192 0.1×	656 0.8×	276 0.3×	135 0.2×	108	4.5k

Countries citing papers authored by Jesper Lau

Since Specialization

Citations

This map shows the geographic impact of Jesper Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Lau more than expected).

Fields of papers citing papers by Jesper Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Lau. The network helps show where Jesper Lau may publish in the future.

Co-authorship network of co-authors of Jesper Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Lau. A scholar is included among the top collaborators of Jesper Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Lau. Jesper Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galsgaard, Katrine D., Jenna Elizabeth Hunt, Hannelouise Kissow, et al.. (2022). Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice. Molecular Metabolism. 66. 101639–101639. 11 indexed citations

Galsgaard, Katrine D., Samuel A.J. Trammell, Marie Winther‐Sørensen, et al.. (2022). Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells. iScience. 25(11). 105296–105296. 17 indexed citations

Simonsen, Lotte, Jesper Lau, Thomas Kruse, et al.. (2022). Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls. PLoS ONE. 17(3). e0264974–e0264974. 26 indexed citations

Euerby, Melvin R., et al.. (2019). Investigation into reversed phase chromatography peptide separation systems part I: Development of a protocol for column characterisation. Journal of Chromatography A. 1603. 113–129. 18 indexed citations

Knudsen, Lotte Bjerre & Jesper Lau. (2019). The Discovery and Development of Liraglutide and Semaglutide. Frontiers in Endocrinology. 10. 155–155. 601 indexed citations breakdown →

Graaf, Chris de, Daniel J Donnelly, Denise Wootten, et al.. (2016). Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes. Pharmacological Reviews. 68(4). 954–1013. 288 indexed citations breakdown →

Nilsson, Cecilia, Thomas Kruse Hansen, Christian Rosenquist, et al.. (2016). Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1. European Journal of Pharmacology. 773. 24–31. 53 indexed citations

Underwood, Christina Rye, Sanne Møller Knudsen, Birgitte S. Wulff, et al.. (2011). Transmembrane α-Helix 2 and 7 Are Important for Small Molecule-Mediated Activation of the GLP-1 Receptor. Pharmacology. 88(5-6). 340–348. 6 indexed citations

Runge, S., Henning Thøgersen, Kjeld Madsen, Jesper Lau, & Rainer Rudolph. (2008). Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain. Journal of Biological Chemistry. 283(17). 11340–11347. 244 indexed citations

10.

Lau, Jesper, Claus Jeppesen, Karin Rimvall, & Rolf Hohlweg. (2006). Ureas with histamine H3-antagonist receptor activity—A new scaffold discovered by lead-hopping from cinnamic acid amides. Bioorganic & Medicinal Chemistry Letters. 16(20). 5303–5308. 24 indexed citations

11.

Lau, Jesper, et al.. (2003). Parallel solid-phase synthesis of disubstituted (5-biphenyltetrazolyl) hydantoins and thiohydantoins targeting the growth hormone secretagogue receptor. Bioorganic & Medicinal Chemistry Letters. 14(2). 317–320. 17 indexed citations

12.

Andersen, Knud Erik, Jesper Lau, Behrend F. Lundt, et al.. (2001). Synthesis of novel GABA uptake inhibitors. part 6 : Preparation and evaluation of N-Ω asymmetrically substituted nipecotic acid derivatives. Bioorganic & Medicinal Chemistry. 9(11). 2773–2785. 31 indexed citations

13.

González, Javier, V. Gregor, Atsuo Kuki, et al.. (2001). Identification of Alkylidene Hydrazides as Glucagon Receptor Antagonists. Journal of Medicinal Chemistry. 44(19). 3141–3149. 34 indexed citations

14.

Soulis, Tina, Stephen A. Sastra, Vicki Thallas, et al.. (1999). A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes. Diabetologia. 42(4). 472–479. 41 indexed citations

15.

Simonsen, Klaus B., Niels Svenstrup, Jesper Lau, N. Thorup, & Jan Becher. (1999). Tetrathiafulvalene Belts with Large Cavities. Angewandte Chemie International Edition. 38(10). 1417–1420. 13 indexed citations

16.

Raun, Kirsten, et al.. (1999). Pharmacological characterisation of a new oral GH secretagogue, NN703. European Journal of Endocrinology. 141(2). 180–189. 50 indexed citations

17.

Simonsen, Klaus B., et al.. (1996). Sequential Functionalisation of Bis-Protected Tetrathiafulvalene-dithiolates. Synthesis. 1996(3). 407–418. 140 indexed citations

18.

Lau, Jesper, et al.. (1991). Synthesis and Evaluation of Antiviral Activity of L-Acosamine and L-Ristosamine Nucleosides of Furanose Configuration.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 45(6). 616–620. 5 indexed citations

19.

Lau, Jesper, et al.. (1991). Free‐radical synthesis of 3‐(2‐cyanoethyl)‐ and 3‐(2‐methoxycarbonylethyl)‐2,3‐dideoxy‐α‐D‐Erythro‐pentofuranoside and their application in the synthesis of potential antiviral nucleosides. Archiv der Pharmazie. 324(12). 953–958. 1 indexed citations

20.

Lau, Jesper, et al.. (1991). Synthesis of 3′‐Amino‐2′,3′‐dideoxy‐hexofuranose Nucleosides with Potential Anti‐Viral Activity. Archiv der Pharmazie. 324(2). 83–89. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact